PPP1R3D expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.869400E-01
Normal-vs-Stage2
9.242600E-01
Normal-vs-Stage3
6.317600E-02
Normal-vs-Stage4
8.876800E-01
Stage1-vs-Stage2
8.824800E-01
Stage1-vs-Stage3
1.525820E-02
Stage1-vs-Stage4
8.270400E-01
Stage2-vs-Stage3
1.601800E-01
Stage2-vs-Stage4
9.259400E-01
Stage3-vs-Stage4
2.832400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.676400E-01
Normal-vs-AfricanAmerican
8.938400E-01
Normal-vs-Asian
9.441000E-01
Caucasian-vs-AfricanAmerican
9.371000E-01
Caucasian-vs-Asian
8.706000E-01
AfricanAmerican-vs-Asian
9.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.997800E-01
Normal-vs-Female
8.547800E-01
Male-vs-Female
9.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.953800E-01
Normal-vs-Age(41-60Yrs)
7.391800E-01
Normal-vs-Age(61-80Yrs)
6.034800E-01
Normal-vs-Age(81-100Yrs)
8.926800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.677000E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.330200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.823400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.680800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.121000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.691000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.566200E-01
Normal-vs-Daily Drinker
8.162600E-01
Normal-vs-Weekly Drinker
5.042600E-01
Normal-vs-Occasional Drinker
5.289400E-01
Normal-vs-Social Drinker
6.058400E-01
Non Drinker-vs-Daily Drinker
4.028800E-01
Non Drinker-vs-Weekly Drinker
8.465200E-01
Non Drinker-vs-Occasional Drinker
3.233800E-02
Non Drinker-vs-Social Drinker
6.500600E-01
Daily Drinker-vs-Weekly Drinker
5.992600E-01
Daily Drinker-vs-Occasional Drinker
9.488200E-02
Daily Drinker-vs-Social Drinker
7.272400E-01
Weekly Drinker-vs-Occasional Drinker
4.690000E-02
Weekly Drinker-vs-Social Drinker
8.411000E-01
Occasional Drinker-vs-Social Drinker
5.977800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.304200E-01
Normal-vs-Grade 2
1.657230E-01
Normal-vs-Grade 3
5.449800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.287200E-01
Grade 1-vs-Grade 3
1.524400E-01
Grade 1-vs-Grade 4
2.304200E-01
Grade 2-vs-Grade 3
9.389600E-01
Grade 2-vs-Grade 4
1.657230E-01
Grade 3-vs-Grade 4
5.449800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.504600E-01
Normal-vs-NonDiabetic
9.960000E-01
Diabetic-vs-NonDiabetic
3.697600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.631800E-01
Normal-vs-NoPancreatitis
8.952000E-01
Pancreatitis-vs-NoPancreatitis
5.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.794000E-01
Normal-vs-N1
9.112000E-01
N0-vs-N1
6.694800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.821800E-01
Normal-vs-TP53-NonMutant
7.843800E-01
TP53-Mutant-vs-TP53-NonMutant
4.935500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
